

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 7.61001162 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.61001162 |
| 3 | L-phenylalanine metabolic process (GO:0006558) | 7.32727923 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.32727923 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 6.88309972 |
| 6 | epoxygenase P450 pathway (GO:0019373) | 6.46119272 |
| 7 | tryptophan catabolic process (GO:0006569) | 6.25692748 |
| 8 | indole-containing compound catabolic process (GO:0042436) | 6.25692748 |
| 9 | indolalkylamine catabolic process (GO:0046218) | 6.25692748 |
| 10 | glyoxylate metabolic process (GO:0046487) | 6.11485846 |
| 11 | kynurenine metabolic process (GO:0070189) | 6.03899965 |
| 12 | omega-hydroxylase P450 pathway (GO:0097267) | 5.96288677 |
| 13 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.93062006 |
| 14 | tryptophan metabolic process (GO:0006568) | 5.89438081 |
| 15 | cysteine metabolic process (GO:0006534) | 5.82436731 |
| 16 | bile acid biosynthetic process (GO:0006699) | 5.77683644 |
| 17 | urea cycle (GO:0000050) | 5.43098553 |
| 18 | urea metabolic process (GO:0019627) | 5.43098553 |
| 19 | sulfur amino acid catabolic process (GO:0000098) | 5.38468964 |
| 20 | alpha-linolenic acid metabolic process (GO:0036109) | 5.37273238 |
| 21 | intestinal cholesterol absorption (GO:0030299) | 5.35380720 |
| 22 | lysine metabolic process (GO:0006553) | 5.31247776 |
| 23 | lysine catabolic process (GO:0006554) | 5.31247776 |
| 24 | serine family amino acid catabolic process (GO:0009071) | 5.29369503 |
| 25 | negative regulation of fibrinolysis (GO:0051918) | 5.25285704 |
| 26 | high-density lipoprotein particle remodeling (GO:0034375) | 5.20136547 |
| 27 | very-low-density lipoprotein particle assembly (GO:0034379) | 5.13435699 |
| 28 | protein carboxylation (GO:0018214) | 5.09927255 |
| 29 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.09927255 |
| 30 | regulation of fibrinolysis (GO:0051917) | 5.04792277 |
| 31 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 5.02938175 |
| 32 | nitrogen cycle metabolic process (GO:0071941) | 5.01994069 |
| 33 | aromatic amino acid family metabolic process (GO:0009072) | 5.01455078 |
| 34 | homocysteine metabolic process (GO:0050667) | 4.97188052 |
| 35 | regulation of protein activation cascade (GO:2000257) | 4.96180373 |
| 36 | complement activation, alternative pathway (GO:0006957) | 4.95326446 |
| 37 | bile acid metabolic process (GO:0008206) | 4.90245490 |
| 38 | amino-acid betaine metabolic process (GO:0006577) | 4.75373165 |
| 39 | alpha-amino acid catabolic process (GO:1901606) | 4.74520488 |
| 40 | tyrosine metabolic process (GO:0006570) | 4.68857259 |
| 41 | drug metabolic process (GO:0017144) | 4.68641384 |
| 42 | regulation of complement activation (GO:0030449) | 4.62806302 |
| 43 | negative regulation of hemostasis (GO:1900047) | 4.61589610 |
| 44 | negative regulation of blood coagulation (GO:0030195) | 4.61589610 |
| 45 | protein activation cascade (GO:0072376) | 4.57433847 |
| 46 | reverse cholesterol transport (GO:0043691) | 4.57162159 |
| 47 | cellular ketone body metabolic process (GO:0046950) | 4.55586417 |
| 48 | * regulation of plasminogen activation (GO:0010755) | 4.55168409 |
| 49 | regulation of triglyceride catabolic process (GO:0010896) | 4.53991962 |
| 50 | regulation of cholesterol esterification (GO:0010872) | 4.53499242 |
| 51 | acute-phase response (GO:0006953) | 4.51378567 |
| 52 | negative regulation of lipase activity (GO:0060192) | 4.47456149 |
| 53 | oxidative demethylation (GO:0070989) | 4.47045554 |
| 54 | serine family amino acid metabolic process (GO:0009069) | 4.45498893 |
| 55 | protein-lipid complex remodeling (GO:0034368) | 4.44692418 |
| 56 | macromolecular complex remodeling (GO:0034367) | 4.44692418 |
| 57 | plasma lipoprotein particle remodeling (GO:0034369) | 4.44692418 |
| 58 | indolalkylamine metabolic process (GO:0006586) | 4.42466738 |
| 59 | negative regulation of cholesterol transport (GO:0032375) | 4.42001362 |
| 60 | negative regulation of sterol transport (GO:0032372) | 4.42001362 |
| 61 | glutamate metabolic process (GO:0006536) | 4.41729811 |
| 62 | cellular amino acid catabolic process (GO:0009063) | 4.41323563 |
| 63 | triglyceride homeostasis (GO:0070328) | 4.40866465 |
| 64 | acylglycerol homeostasis (GO:0055090) | 4.40866465 |
| 65 | plasma lipoprotein particle organization (GO:0071827) | 4.40742432 |
| 66 | negative regulation of protein activation cascade (GO:2000258) | 4.40530832 |
| 67 | glycine metabolic process (GO:0006544) | 4.39877324 |
| 68 | phenylpropanoid metabolic process (GO:0009698) | 4.38924374 |
| 69 | cellular modified amino acid catabolic process (GO:0042219) | 4.36223928 |
| 70 | protein-lipid complex assembly (GO:0065005) | 4.33944681 |
| 71 | coenzyme catabolic process (GO:0009109) | 4.32427972 |
| 72 | amine catabolic process (GO:0009310) | 4.31842504 |
| 73 | cellular biogenic amine catabolic process (GO:0042402) | 4.31842504 |
| 74 | drug catabolic process (GO:0042737) | 4.29400775 |
| 75 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 4.25311180 |
| 76 | phospholipid efflux (GO:0033700) | 4.24268268 |
| 77 | serine family amino acid biosynthetic process (GO:0009070) | 4.23557544 |
| 78 | negative regulation of coagulation (GO:0050819) | 4.21309771 |
| 79 | urate metabolic process (GO:0046415) | 4.20578657 |
| 80 | regulation of humoral immune response (GO:0002920) | 4.19866353 |
| 81 | benzene-containing compound metabolic process (GO:0042537) | 4.19854117 |
| 82 | cellular glucuronidation (GO:0052695) | 4.19139868 |
| 83 | drug transmembrane transport (GO:0006855) | 4.17247616 |
| 84 | imidazole-containing compound metabolic process (GO:0052803) | 4.17211448 |
| 85 | ethanol metabolic process (GO:0006067) | 4.14972526 |
| 86 | complement activation, classical pathway (GO:0006958) | 4.14724465 |
| 87 | bile acid and bile salt transport (GO:0015721) | 4.13713633 |
| 88 | protein-lipid complex subunit organization (GO:0071825) | 4.12813061 |
| 89 | regulation of apoptotic cell clearance (GO:2000425) | 4.11143473 |
| 90 | plasma lipoprotein particle clearance (GO:0034381) | 4.10388478 |
| 91 | negative regulation of wound healing (GO:0061045) | 4.09010274 |
| 92 | positive regulation of hemostasis (GO:1900048) | 4.08465616 |
| 93 | positive regulation of blood coagulation (GO:0030194) | 4.08465616 |
| 94 | ethanol oxidation (GO:0006069) | 4.06160965 |
| 95 | aldehyde catabolic process (GO:0046185) | 4.03611912 |
| 96 | complement activation (GO:0006956) | 4.02010735 |
| 97 | short-chain fatty acid metabolic process (GO:0046459) | 4.00135041 |
| 98 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.99494268 |
| 99 | ketone body metabolic process (GO:1902224) | 3.93991995 |
| 100 | arginine metabolic process (GO:0006525) | 3.91239345 |
| 101 | aspartate family amino acid catabolic process (GO:0009068) | 3.90565603 |
| 102 | cholesterol efflux (GO:0033344) | 3.88820251 |
| 103 | carboxylic acid catabolic process (GO:0046395) | 3.87016582 |
| 104 | organic acid catabolic process (GO:0016054) | 3.87016582 |
| 105 | acetyl-CoA metabolic process (GO:0006084) | 3.83556154 |
| 106 | exogenous drug catabolic process (GO:0042738) | 3.81347544 |
| 107 | fibrinolysis (GO:0042730) | 3.79663396 |
| 108 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.78592649 |
| 109 | glucuronate metabolic process (GO:0019585) | 3.78548835 |
| 110 | uronic acid metabolic process (GO:0006063) | 3.78548835 |
| 111 | positive regulation of coagulation (GO:0050820) | 3.76903357 |
| 112 | proline metabolic process (GO:0006560) | 3.74908918 |
| 113 | regulation of cholesterol homeostasis (GO:2000188) | 3.73923333 |
| 114 | S-adenosylmethionine metabolic process (GO:0046500) | 3.72345370 |
| 115 | plasma lipoprotein particle assembly (GO:0034377) | 3.72227405 |
| 116 | 2-oxoglutarate metabolic process (GO:0006103) | 3.70075031 |
| 117 | regulation of bile acid biosynthetic process (GO:0070857) | 3.69996251 |
| 118 | cofactor catabolic process (GO:0051187) | 3.69087583 |
| 119 | opsonization (GO:0008228) | 3.64911578 |
| 120 | low-density lipoprotein particle remodeling (GO:0034374) | 3.64248968 |
| 121 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.63641190 |
| 122 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.63641190 |
| 123 | positive regulation of lipid catabolic process (GO:0050996) | 3.61459980 |
| 124 | phospholipid homeostasis (GO:0055091) | 3.57905206 |
| 125 | blood coagulation, intrinsic pathway (GO:0007597) | 3.57747980 |
| 126 | monocarboxylic acid catabolic process (GO:0072329) | 3.55750286 |
| 127 | fatty acid oxidation (GO:0019395) | 3.54833650 |
| 128 | fatty acid beta-oxidation (GO:0006635) | 3.54169957 |
| 129 | response to nitrosative stress (GO:0051409) | 3.52144883 |
| 130 | lipoprotein metabolic process (GO:0042157) | 3.51945246 |
| 131 | negative regulation of complement activation (GO:0045916) | 3.51829270 |
| 132 | carnitine metabolic process (GO:0009437) | 3.51463250 |
| 133 | NAD biosynthetic process (GO:0009435) | 3.51411113 |
| 134 | pyridine nucleotide biosynthetic process (GO:0019363) | 3.51270086 |
| 135 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.51270086 |
| 136 | acute inflammatory response (GO:0002526) | 3.48547626 |
| 137 | heme transport (GO:0015886) | 3.48085361 |
| 138 | cytolysis (GO:0019835) | 3.47823977 |
| 139 | flavonoid metabolic process (GO:0009812) | 3.46120119 |
| 140 | regulation of lipoprotein particle clearance (GO:0010984) | 3.43353138 |
| 141 | cholesterol transport (GO:0030301) | 3.41028810 |
| 142 | sterol transport (GO:0015918) | 3.41028810 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.35426823 |
| 2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.18199824 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.70449912 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.43550881 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.18549374 |
| 6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.98909636 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.97434084 |
| 8 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.98953010 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.95516867 |
| 10 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.18950191 |
| 11 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.14478289 |
| 12 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.10978181 |
| 13 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.8896613 |
| 14 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.64298429 |
| 15 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.60359291 |
| 16 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.44761836 |
| 17 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.43312177 |
| 18 | GATA1_22025678_ChIP-Seq_K562_Human | 1.42577313 |
| 19 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.41800906 |
| 20 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.33183280 |
| 21 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.30422925 |
| 22 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.27157274 |
| 23 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.19127026 |
| 24 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.13481887 |
| 25 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.08760223 |
| 26 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.08713129 |
| 27 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.05315810 |
| 28 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.03178648 |
| 29 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.00595754 |
| 30 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.98084730 |
| 31 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.96622738 |
| 32 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.96620907 |
| 33 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.94762595 |
| 34 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.94492084 |
| 35 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.93727880 |
| 36 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.90250061 |
| 37 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.87653147 |
| 38 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.87093422 |
| 39 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.86912089 |
| 40 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.85450035 |
| 41 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.83844861 |
| 42 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.82626371 |
| 43 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.82056499 |
| 44 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.79961922 |
| 45 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.78376280 |
| 46 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.77844285 |
| 47 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.77744715 |
| 48 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.77300756 |
| 49 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.77079467 |
| 50 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.76727673 |
| 51 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.76420963 |
| 52 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.76367348 |
| 53 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.74925189 |
| 54 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.74450532 |
| 55 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.73780911 |
| 56 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 0.73115665 |
| 57 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.72521429 |
| 58 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.72388186 |
| 59 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.72327461 |
| 60 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.72298824 |
| 61 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.72173874 |
| 62 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.71917823 |
| 63 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.71557258 |
| 64 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.70186862 |
| 65 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.69435004 |
| 66 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.69214928 |
| 67 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.68303962 |
| 68 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.67421384 |
| 69 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.66683633 |
| 70 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.66392425 |
| 71 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.66158871 |
| 72 | NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 0.65302610 |
| 73 | * OCT4_20526341_ChIP-Seq_ESCs_Human | 0.65008263 |
| 74 | P68_20966046_ChIP-Seq_HELA_Human | 0.63721950 |
| 75 | * RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.63421161 |
| 76 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.63078161 |
| 77 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.61512206 |
| 78 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.61474216 |
| 79 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.61299362 |
| 80 | * SOX2_21211035_ChIP-Seq_LN229_Human | 0.61122689 |
| 81 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.59310884 |
| 82 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.59093760 |
| 83 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.58104568 |
| 84 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.57163247 |
| 85 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.56629780 |
| 86 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.56629780 |
| 87 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.56468232 |
| 88 | AR_20517297_ChIP-Seq_VCAP_Human | 0.55201171 |
| 89 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.55172092 |
| 90 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.54069597 |
| 91 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.53728206 |
| 92 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.53341487 |
| 93 | SA1_27219007_Chip-Seq_Bcells_Human | 0.52608766 |
| 94 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.51233106 |
| 95 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.50574204 |
| 96 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.50061904 |
| 97 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.49613210 |
| 98 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.49554107 |
| 99 | * FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.49498403 |
| 100 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.48961546 |
| 101 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.48578336 |
| 102 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.47798126 |
| 103 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.47299789 |
| 104 | GATA1_19941826_ChIP-Seq_K562_Human | 0.47200155 |
| 105 | CBP_21632823_ChIP-Seq_H3396_Human | 0.46849352 |
| 106 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.46362403 |
| 107 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.46047212 |
| 108 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.45526966 |
| 109 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.45447619 |
| 110 | GATA2_19941826_ChIP-Seq_K562_Human | 0.44889215 |
| 111 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.44409297 |
| 112 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.43796818 |
| 113 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.43673034 |
| 114 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.42602139 |
| 115 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.41306235 |
| 116 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.40722109 |
| 117 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.40354567 |
| 118 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.39703865 |
| 119 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 0.38491720 |
| 120 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.38002367 |
| 121 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.37794118 |
| 122 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.37361952 |
| 123 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.36929548 |
| 124 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.36598263 |
| 125 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.36564819 |
| 126 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.36285121 |
| 127 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.35467715 |
| 128 | SOX3_22085726_ChIP-Seq_MUSCLE_Mouse | 0.35452016 |
| 129 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.35315965 |
| 130 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.35297715 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.17301614 |
| 2 | MP0005360_urolithiasis | 7.70849778 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.17812030 |
| 4 | MP0005365_abnormal_bile_salt | 6.01422195 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.02310234 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.12252995 |
| 7 | MP0003252_abnormal_bile_duct | 3.85875190 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.38109927 |
| 9 | MP0005332_abnormal_amino_acid | 3.12168966 |
| 10 | MP0005083_abnormal_biliary_tract | 3.11294066 |
| 11 | MP0003195_calcinosis | 3.11090167 |
| 12 | MP0009840_abnormal_foam_cell | 3.04897050 |
| 13 | MP0001666_abnormal_nutrient_absorption | 2.69062129 |
| 14 | MP0004019_abnormal_vitamin_homeostasis | 2.51665312 |
| 15 | MP0002138_abnormal_hepatobiliary_system | 2.36439928 |
| 16 | MP0003191_abnormal_cellular_cholesterol | 2.33859367 |
| 17 | MP0000609_abnormal_liver_physiology | 2.07941684 |
| 18 | MP0002118_abnormal_lipid_homeostasis | 2.04788265 |
| 19 | MP0003868_abnormal_feces_composition | 1.82672223 |
| 20 | * MP0005319_abnormal_enzyme/_coenzyme | 1.78800881 |
| 21 | MP0001764_abnormal_homeostasis | 1.67816390 |
| 22 | MP0009643_abnormal_urine_homeostasis | 1.62521842 |
| 23 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.61830485 |
| 24 | MP0005451_abnormal_body_composition | 1.51259459 |
| 25 | MP0003186_abnormal_redox_activity | 1.42366375 |
| 26 | MP0000566_synostosis | 1.36896707 |
| 27 | MP0003122_maternal_imprinting | 1.32453264 |
| 28 | MP0003656_abnormal_erythrocyte_physiolo | 1.28809489 |
| 29 | MP0009697_abnormal_copulation | 1.27083299 |
| 30 | MP0005636_abnormal_mineral_homeostasis | 1.25290714 |
| 31 | MP0003011_delayed_dark_adaptation | 1.21536278 |
| 32 | MP0000598_abnormal_liver_morphology | 1.16904666 |
| 33 | MP0003705_abnormal_hypodermis_morpholog | 1.10932294 |
| 34 | MP0009764_decreased_sensitivity_to | 1.05291395 |
| 35 | MP0005647_abnormal_sex_gland | 1.04334581 |
| 36 | MP0000604_amyloidosis | 1.01864721 |
| 37 | MP0005084_abnormal_gallbladder_morpholo | 1.00843646 |
| 38 | MP0002132_abnormal_respiratory_system | 0.97415608 |
| 39 | MP0002254_reproductive_system_inflammat | 0.97312867 |
| 40 | MP0009763_increased_sensitivity_to | 0.94804184 |
| 41 | MP0001915_intracranial_hemorrhage | 0.94218271 |
| 42 | MP0006036_abnormal_mitochondrial_physio | 0.94180596 |
| 43 | MP0001756_abnormal_urination | 0.93956250 |
| 44 | MP0005220_abnormal_exocrine_pancreas | 0.90710794 |
| 45 | * MP0009642_abnormal_blood_homeostasis | 0.88660339 |
| 46 | MP0002089_abnormal_postnatal_growth/wei | 0.87570067 |
| 47 | MP0004043_abnormal_pH_regulation | 0.87157492 |
| 48 | * MP0008469_abnormal_protein_level | 0.86856092 |
| 49 | MP0005408_hypopigmentation | 0.85907308 |
| 50 | MP0003172_abnormal_lysosome_physiology | 0.85131203 |
| 51 | MP0005670_abnormal_white_adipose | 0.85090910 |
| 52 | MP0010368_abnormal_lymphatic_system | 0.83699574 |
| 53 | * MP0002876_abnormal_thyroid_physiology | 0.83484284 |
| 54 | MP0002078_abnormal_glucose_homeostasis | 0.77957498 |
| 55 | MP0002136_abnormal_kidney_physiology | 0.77424728 |
| 56 | MP0005376_homeostasis/metabolism_phenot | 0.76966304 |
| 57 | MP0009765_abnormal_xenobiotic_induced | 0.75110770 |
| 58 | MP0002909_abnormal_adrenal_gland | 0.73245203 |
| 59 | MP0005535_abnormal_body_temperature | 0.71256027 |
| 60 | MP0003123_paternal_imprinting | 0.68321808 |
| 61 | MP0002971_abnormal_brown_adipose | 0.67547745 |
| 62 | MP0001661_extended_life_span | 0.66875336 |
| 63 | MP0005167_abnormal_blood-brain_barrier | 0.66529750 |
| 64 | MP0002249_abnormal_larynx_morphology | 0.64972167 |
| 65 | MP0005334_abnormal_fat_pad | 0.63494383 |
| 66 | MP0003329_amyloid_beta_deposits | 0.63061450 |
| 67 | MP0002928_abnormal_bile_duct | 0.61640695 |
| 68 | MP0005266_abnormal_metabolism | 0.61317087 |
| 69 | MP0002282_abnormal_trachea_morphology | 0.60001190 |
| 70 | MP0006035_abnormal_mitochondrial_morpho | 0.59803629 |
| 71 | MP0009053_abnormal_anal_canal | 0.59115264 |
| 72 | MP0004130_abnormal_muscle_cell | 0.58341820 |
| 73 | MP0009780_abnormal_chondrocyte_physiolo | 0.57864372 |
| 74 | MP0001765_abnormal_ion_homeostasis | 0.56199858 |
| 75 | MP0003690_abnormal_glial_cell | 0.55976866 |
| 76 | MP0003638_abnormal_response/metabolism_ | 0.55453335 |
| 77 | MP0005395_other_phenotype | 0.53331871 |
| 78 | MP0003878_abnormal_ear_physiology | 0.52407508 |
| 79 | MP0005377_hearing/vestibular/ear_phenot | 0.52407508 |
| 80 | MP0005448_abnormal_energy_balance | 0.49232968 |
| 81 | MP0000639_abnormal_adrenal_gland | 0.47575959 |
| 82 | MP0005058_abnormal_lysosome_morphology | 0.46878700 |
| 83 | MP0003183_abnormal_peptide_metabolism | 0.45750535 |
| 84 | MP0003724_increased_susceptibility_to | 0.45140479 |
| 85 | MP0005464_abnormal_platelet_physiology | 0.45138609 |
| 86 | MP0005666_abnormal_adipose_tissue | 0.43887347 |
| 87 | MP0001944_abnormal_pancreas_morphology | 0.43224481 |
| 88 | MP0005187_abnormal_penis_morphology | 0.43145183 |
| 89 | MP0003718_maternal_effect | 0.42598787 |
| 90 | MP0002168_other_aberrant_phenotype | 0.42201476 |
| 91 | MP0004782_abnormal_surfactant_physiolog | 0.42086787 |
| 92 | MP0008873_increased_physiological_sensi | 0.41116820 |
| 93 | * MP0003953_abnormal_hormone_level | 0.40715955 |
| 94 | MP0000230_abnormal_systemic_arterial | 0.40545054 |
| 95 | MP0008874_decreased_physiological_sensi | 0.40509679 |
| 96 | MP0003075_altered_response_to | 0.40233416 |
| 97 | MP0004272_abnormal_basement_membrane | 0.39230174 |
| 98 | MP0002796_impaired_skin_barrier | 0.39187203 |
| 99 | MP0008872_abnormal_physiological_respon | 0.39027236 |
| 100 | MP0005646_abnormal_pituitary_gland | 0.38600415 |
| 101 | MP0000003_abnormal_adipose_tissue | 0.38331711 |
| 102 | MP0005164_abnormal_response_to | 0.37929572 |
| 103 | MP0004883_abnormal_blood_vessel | 0.37917732 |
| 104 | MP0009672_abnormal_birth_weight | 0.37819352 |
| 105 | MP0005166_decreased_susceptibility_to | 0.37320692 |
| 106 | MP0003436_decreased_susceptibility_to | 0.37173870 |
| 107 | MP0004264_abnormal_extraembryonic_tissu | 0.36140835 |
| 108 | MP0002135_abnormal_kidney_morphology | 0.35086491 |
| 109 | MP0004858_abnormal_nervous_system | 0.31781434 |
| 110 | MP0005379_endocrine/exocrine_gland_phen | 0.31526443 |
| 111 | MP0002822_catalepsy | 0.31411906 |
| 112 | MP0002837_dystrophic_cardiac_calcinosis | 0.31391636 |
| 113 | MP0001845_abnormal_inflammatory_respons | 0.30996166 |
| 114 | MP0000538_abnormal_urinary_bladder | 0.30390004 |
| 115 | MP0005375_adipose_tissue_phenotype | 0.29753076 |
| 116 | MP0005023_abnormal_wound_healing | 0.29481353 |
| 117 | MP0009115_abnormal_fat_cell | 0.29302344 |
| 118 | MP0004147_increased_porphyrin_level | 0.28863151 |
| 119 | MP0002970_abnormal_white_adipose | 0.28314894 |
| 120 | MP0003300_gastrointestinal_ulcer | 0.27901606 |
| 121 | MP0009384_cardiac_valve_regurgitation | 0.27771510 |
| 122 | MP0003959_abnormal_lean_body | 0.27667190 |
| 123 | MP0006082_CNS_inflammation | 0.27442123 |
| 124 | MP0005248_abnormal_Harderian_gland | 0.27224335 |
| 125 | MP0000579_abnormal_nail_morphology | 0.27214902 |
| 126 | MP0001853_heart_inflammation | 0.27014483 |
| 127 | MP0000249_abnormal_blood_vessel | 0.26496985 |
| 128 | MP0005409_darkened_coat_color | 0.25746647 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.23590333 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 6.79812226 |
| 3 | Deep venous thrombosis (HP:0002625) | 6.78417489 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.31332465 |
| 5 | Xanthomatosis (HP:0000991) | 5.95234269 |
| 6 | Prolonged partial thromboplastin time (HP:0003645) | 5.92185560 |
| 7 | Hypobetalipoproteinemia (HP:0003563) | 5.79167549 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.11599202 |
| 9 | Complement deficiency (HP:0004431) | 4.83763567 |
| 10 | Hyperammonemia (HP:0001987) | 4.66237603 |
| 11 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.56445271 |
| 12 | Ketosis (HP:0001946) | 4.53811625 |
| 13 | Hyperglycinemia (HP:0002154) | 4.52716788 |
| 14 | Joint hemorrhage (HP:0005261) | 4.47491796 |
| 15 | Hyperglycinuria (HP:0003108) | 4.42041104 |
| 16 | Hypolipoproteinemia (HP:0010981) | 4.35946813 |
| 17 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.29986456 |
| 18 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.27797622 |
| 19 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.26908920 |
| 20 | Abnormality of glycine metabolism (HP:0010895) | 4.26908920 |
| 21 | Abnormality of the common coagulation pathway (HP:0010990) | 4.13164123 |
| 22 | Epidermoid cyst (HP:0200040) | 4.05758117 |
| 23 | Abnormality of methionine metabolism (HP:0010901) | 4.03613188 |
| 24 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.97152375 |
| 25 | Fat malabsorption (HP:0002630) | 3.91867618 |
| 26 | Hypoalphalipoproteinemia (HP:0003233) | 3.85457472 |
| 27 | Hypoglycemic coma (HP:0001325) | 3.82901175 |
| 28 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.71079967 |
| 29 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.61534930 |
| 30 | Gout (HP:0001997) | 3.60837438 |
| 31 | Abnormality of the intrinsic pathway (HP:0010989) | 3.50194732 |
| 32 | Abnormality of complement system (HP:0005339) | 3.50017767 |
| 33 | Nephritis (HP:0000123) | 3.48069381 |
| 34 | Ketoacidosis (HP:0001993) | 3.43487895 |
| 35 | Abnormality of nucleobase metabolism (HP:0010932) | 3.42270719 |
| 36 | Conjugated hyperbilirubinemia (HP:0002908) | 3.40926664 |
| 37 | Delayed CNS myelination (HP:0002188) | 3.31882206 |
| 38 | Abnormality of purine metabolism (HP:0004352) | 3.27866094 |
| 39 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.27469015 |
| 40 | Hyperbilirubinemia (HP:0002904) | 3.24644056 |
| 41 | Hypercholesterolemia (HP:0003124) | 3.24264672 |
| 42 | Abnormality of serum amino acid levels (HP:0003112) | 3.11569417 |
| 43 | Steatorrhea (HP:0002570) | 3.00006111 |
| 44 | Hepatocellular carcinoma (HP:0001402) | 2.99361326 |
| 45 | Metabolic acidosis (HP:0001942) | 2.96017263 |
| 46 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.82206378 |
| 47 | Dicarboxylic aciduria (HP:0003215) | 2.82206378 |
| 48 | Vascular calcification (HP:0004934) | 2.82166265 |
| 49 | Lethargy (HP:0001254) | 2.76681992 |
| 50 | Spontaneous abortion (HP:0005268) | 2.72502588 |
| 51 | Myocardial infarction (HP:0001658) | 2.69951145 |
| 52 | Purpura (HP:0000979) | 2.67964144 |
| 53 | Systemic lupus erythematosus (HP:0002725) | 2.60036032 |
| 54 | Generalized aminoaciduria (HP:0002909) | 2.59614488 |
| 55 | Hypochromic microcytic anemia (HP:0004840) | 2.58162401 |
| 56 | Spastic diplegia (HP:0001264) | 2.52208922 |
| 57 | Alkalosis (HP:0001948) | 2.49540587 |
| 58 | Cardiovascular calcification (HP:0011915) | 2.49358714 |
| 59 | Increased purine levels (HP:0004368) | 2.47566840 |
| 60 | Hyperuricemia (HP:0002149) | 2.47566840 |
| 61 | Skin nodule (HP:0200036) | 2.46780133 |
| 62 | Malnutrition (HP:0004395) | 2.46684084 |
| 63 | Cerebral edema (HP:0002181) | 2.46563041 |
| 64 | Proximal tubulopathy (HP:0000114) | 2.46404283 |
| 65 | Irritability (HP:0000737) | 2.44339256 |
| 66 | Neonatal onset (HP:0003623) | 2.43871851 |
| 67 | Hypoglycemic seizures (HP:0002173) | 2.37525772 |
| 68 | Enlarged kidneys (HP:0000105) | 2.34063155 |
| 69 | Vomiting (HP:0002013) | 2.33505010 |
| 70 | Acanthocytosis (HP:0001927) | 2.28294323 |
| 71 | Late onset (HP:0003584) | 2.27695352 |
| 72 | Abnormal gallbladder morphology (HP:0012437) | 2.26704059 |
| 73 | Mitral stenosis (HP:0001718) | 2.25781534 |
| 74 | Glomerulonephritis (HP:0000099) | 2.23365666 |
| 75 | Cholelithiasis (HP:0001081) | 2.22809912 |
| 76 | Osteomalacia (HP:0002749) | 2.21080577 |
| 77 | Pancreatitis (HP:0001733) | 2.20704276 |
| 78 | Abnormality of proline metabolism (HP:0010907) | 2.20041401 |
| 79 | Hydroxyprolinuria (HP:0003080) | 2.20041401 |
| 80 | Sensorimotor neuropathy (HP:0007141) | 2.18860464 |
| 81 | Rickets (HP:0002748) | 2.17715499 |
| 82 | Esophageal varix (HP:0002040) | 2.16404670 |
| 83 | Abnormal gallbladder physiology (HP:0012438) | 2.15177761 |
| 84 | Cholecystitis (HP:0001082) | 2.15177761 |
| 85 | Glycosuria (HP:0003076) | 2.12970013 |
| 86 | Abnormality of urine glucose concentration (HP:0011016) | 2.12970013 |
| 87 | Abnormality of the Achilles tendon (HP:0005109) | 2.11844380 |
| 88 | Pulmonary embolism (HP:0002204) | 2.10971503 |
| 89 | Amyloidosis (HP:0011034) | 2.10667167 |
| 90 | Bifid scrotum (HP:0000048) | 2.10639722 |
| 91 | Brushfield spots (HP:0001088) | 2.09265583 |
| 92 | Opisthotonus (HP:0002179) | 2.08522617 |
| 93 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.04531144 |
| 94 | Arthropathy (HP:0003040) | 2.03519570 |
| 95 | Thrombophlebitis (HP:0004418) | 2.03336210 |
| 96 | Abnormal enzyme/coenzyme activity (HP:0012379) | 2.01616840 |
| 97 | Menorrhagia (HP:0000132) | 2.01059732 |
| 98 | Abnormal tarsal ossification (HP:0008369) | 1.95914528 |
| 99 | Gingival bleeding (HP:0000225) | 1.94946123 |
| 100 | Hypophosphatemic rickets (HP:0004912) | 1.94373957 |
| 101 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.91849202 |
| 102 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.91625244 |
| 103 | Joint swelling (HP:0001386) | 1.89328941 |
| 104 | Hemorrhage of the eye (HP:0011885) | 1.89286359 |
| 105 | Abnormality of vitamin metabolism (HP:0100508) | 1.88684116 |
| 106 | Retinal atrophy (HP:0001105) | 1.88579437 |
| 107 | Abnormality of the gallbladder (HP:0005264) | 1.88449072 |
| 108 | Abnormal cartilage morphology (HP:0002763) | 1.87906995 |
| 109 | Abnormality of iron homeostasis (HP:0011031) | 1.87448823 |
| 110 | Fair hair (HP:0002286) | 1.86655277 |
| 111 | Poikilocytosis (HP:0004447) | 1.83837311 |
| 112 | Hyperphosphaturia (HP:0003109) | 1.81453319 |
| 113 | Nephrolithiasis (HP:0000787) | 1.80733282 |
| 114 | Abnormality of carpal bone ossification (HP:0006257) | 1.79545721 |
| 115 | Facial shape deformation (HP:0011334) | 1.75727260 |
| 116 | Potter facies (HP:0002009) | 1.75727260 |
| 117 | Reduced antithrombin III activity (HP:0001976) | 1.74241791 |
| 118 | Increased serum ferritin (HP:0003281) | 1.69169065 |
| 119 | Elevated alkaline phosphatase (HP:0003155) | 1.67469724 |
| 120 | Neonatal hypoglycemia (HP:0001998) | 1.67074511 |
| 121 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.66666573 |
| 122 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.61853324 |
| 123 | Mucopolysacchariduria (HP:0008155) | 1.61853324 |
| 124 | Increased serum pyruvate (HP:0003542) | 1.61111318 |
| 125 | Abnormal urine phosphate concentration (HP:0012599) | 1.57481412 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 7.62290646 |
| 2 | ERN1 | 4.44560160 |
| 3 | FGFR4 | 4.42331252 |
| 4 | SIK1 | 4.06684376 |
| 5 | AKT3 | 3.23965434 |
| 6 | INSRR | 2.74474135 |
| 7 | TAOK3 | 2.65996937 |
| 8 | ERBB4 | 2.55801655 |
| 9 | MST1R | 2.18460278 |
| 10 | NTRK3 | 2.16394188 |
| 11 | PKN2 | 2.09743177 |
| 12 | WNK3 | 2.01988543 |
| 13 | MAP2K4 | 1.99047192 |
| 14 | TNK2 | 1.89798745 |
| 15 | WNK4 | 1.88418896 |
| 16 | MAPK11 | 1.81857519 |
| 17 | TRIB3 | 1.81760058 |
| 18 | FLT3 | 1.77566188 |
| 19 | FER | 1.76590580 |
| 20 | EEF2K | 1.74632503 |
| 21 | PIK3CA | 1.68029530 |
| 22 | PIK3CG | 1.58327047 |
| 23 | TYK2 | 1.56398388 |
| 24 | LATS1 | 1.51238234 |
| 25 | EPHA2 | 1.50977895 |
| 26 | STK38L | 1.50324585 |
| 27 | PTK6 | 1.48144160 |
| 28 | ABL2 | 1.44130098 |
| 29 | OXSR1 | 1.40107058 |
| 30 | CAMK1G | 1.38190204 |
| 31 | DAPK2 | 1.36085601 |
| 32 | PINK1 | 1.30869966 |
| 33 | KDR | 1.26125471 |
| 34 | NEK9 | 1.22015927 |
| 35 | MAP3K7 | 1.19834722 |
| 36 | FGFR1 | 1.17166933 |
| 37 | TAOK1 | 1.17031113 |
| 38 | FRK | 1.16919354 |
| 39 | MAPKAPK3 | 1.16665159 |
| 40 | MAP2K3 | 1.16647981 |
| 41 | JAK2 | 1.15111140 |
| 42 | GRK6 | 1.14180891 |
| 43 | MAP3K3 | 1.12260368 |
| 44 | PRKAA2 | 1.05471861 |
| 45 | MAPK15 | 1.03545381 |
| 46 | FGFR2 | 0.98178290 |
| 47 | EPHB1 | 0.96658813 |
| 48 | TBK1 | 0.95193324 |
| 49 | ERBB2 | 0.93443742 |
| 50 | MAP3K2 | 0.92052333 |
| 51 | PDGFRA | 0.90664121 |
| 52 | MAP3K11 | 0.90148933 |
| 53 | MAP3K10 | 0.90109891 |
| 54 | MAP3K14 | 0.87997234 |
| 55 | PRKD3 | 0.87611073 |
| 56 | MET | 0.86320987 |
| 57 | TIE1 | 0.86110896 |
| 58 | PRKCZ | 0.85964319 |
| 59 | DYRK1B | 0.84408705 |
| 60 | MAPK4 | 0.82119374 |
| 61 | JAK1 | 0.80063764 |
| 62 | GSK3A | 0.78436625 |
| 63 | TGFBR2 | 0.78042975 |
| 64 | WNK1 | 0.76228473 |
| 65 | MAPK12 | 0.75009500 |
| 66 | IRAK3 | 0.73319894 |
| 67 | PAK3 | 0.73058435 |
| 68 | MARK2 | 0.72172463 |
| 69 | SGK3 | 0.72048132 |
| 70 | CDK6 | 0.70701488 |
| 71 | CDK12 | 0.70429489 |
| 72 | NLK | 0.68502129 |
| 73 | CHUK | 0.68170366 |
| 74 | PRKACG | 0.67969200 |
| 75 | PTK2 | 0.67911901 |
| 76 | PRKD2 | 0.67596673 |
| 77 | MAP2K6 | 0.67426903 |
| 78 | PRKAA1 | 0.67196624 |
| 79 | SGK1 | 0.66328075 |
| 80 | TYRO3 | 0.66122882 |
| 81 | SGK494 | 0.65590818 |
| 82 | SGK223 | 0.65590818 |
| 83 | SMG1 | 0.64100805 |
| 84 | PDK3 | 0.63959502 |
| 85 | PDK4 | 0.63959502 |
| 86 | RIPK1 | 0.61222488 |
| 87 | NEK1 | 0.58672079 |
| 88 | CSK | 0.58458570 |
| 89 | SGK2 | 0.58035793 |
| 90 | EPHA3 | 0.57095274 |
| 91 | CAMK2G | 0.56768893 |
| 92 | PDPK1 | 0.52814846 |
| 93 | CSNK1E | 0.50956453 |
| 94 | TAOK2 | 0.50528515 |
| 95 | CDC42BPA | 0.49987519 |
| 96 | CAMK1D | 0.44960485 |
| 97 | IKBKE | 0.44112113 |
| 98 | CSNK1D | 0.44085441 |
| 99 | PRKACA | 0.43093612 |
| 100 | MAPK7 | 0.42315182 |
| 101 | MAP2K2 | 0.42309295 |
| 102 | CDK7 | 0.40757032 |
| 103 | CSNK1G1 | 0.40138569 |
| 104 | PRKCI | 0.39525559 |
| 105 | GRK1 | 0.39277248 |
| 106 | MAP3K5 | 0.39144743 |
| 107 | CDK4 | 0.38478512 |
| 108 | PRKCQ | 0.38454650 |
| 109 | MAP2K1 | 0.38372407 |
| 110 | PIM2 | 0.38123546 |
| 111 | PRKG1 | 0.38116358 |
| 112 | CSF1R | 0.37254815 |
| 113 | FGFR3 | 0.36710605 |
| 114 | IGF1R | 0.35456749 |
| 115 | MTOR | 0.35406671 |
| 116 | EIF2AK1 | 0.35218126 |
| 117 | MAPK3 | 0.34676847 |
| 118 | RPS6KA3 | 0.31816217 |
| 119 | PDK2 | 0.31783627 |
| 120 | STK38 | 0.30593616 |
| 121 | RPS6KB1 | 0.29833460 |
| 122 | MATK | 0.29683940 |
| 123 | SRC | 0.29332058 |
| 124 | PDK1 | 0.29161155 |
| 125 | RET | 0.28629741 |
| 126 | LATS2 | 0.28604113 |
| 127 | AKT2 | 0.28554628 |
| 128 | DDR2 | 0.27862694 |
| 129 | EGFR | 0.27607493 |
| 130 | PRKCG | 0.26898410 |
| 131 | MAP3K1 | 0.26893291 |
| 132 | MAP3K6 | 0.26822378 |
| 133 | PHKG2 | 0.26681280 |
| 134 | CAMK4 | 0.25378819 |
| 135 | EPHA4 | 0.24215513 |
| 136 | IRAK1 | 0.24091709 |
| 137 | STK39 | 0.23565445 |
| 138 | IRAK2 | 0.23063294 |
| 139 | PRKCA | 0.22838071 |
| 140 | ICK | 0.21604932 |
| 141 | MAP3K13 | 0.20744840 |
| 142 | LRRK2 | 0.19900932 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.26208617 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.40972565 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.34235630 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.31113726 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.95846450 |
| 6 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.75002471 |
| 7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.69236213 |
| 8 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.60872421 |
| 9 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.58490795 |
| 10 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.53224681 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.53083318 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.52704847 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.36492291 |
| 14 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.32370995 |
| 15 | Peroxisome_Homo sapiens_hsa04146 | 2.17396658 |
| 16 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.08401699 |
| 17 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.05847651 |
| 18 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.86365163 |
| 19 | Histidine metabolism_Homo sapiens_hsa00340 | 1.85596189 |
| 20 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.83294396 |
| 21 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.82591893 |
| 22 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.82551595 |
| 23 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.82293267 |
| 24 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.79756381 |
| 25 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.77338199 |
| 26 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.75445971 |
| 27 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.70282698 |
| 28 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.69644621 |
| 29 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.64286618 |
| 30 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.61907684 |
| 31 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.60156434 |
| 32 | Retinol metabolism_Homo sapiens_hsa00830 | 1.59876038 |
| 33 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.56724438 |
| 34 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.52286160 |
| 35 | Bile secretion_Homo sapiens_hsa04976 | 1.52264890 |
| 36 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.50730461 |
| 37 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.43023729 |
| 38 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.39823507 |
| 39 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.35304399 |
| 40 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.35034819 |
| 41 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.34774432 |
| 42 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.31312575 |
| 43 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.28383137 |
| 44 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.27169426 |
| 45 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.24733130 |
| 46 | Carbon metabolism_Homo sapiens_hsa01200 | 1.21513044 |
| 47 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.14891754 |
| 48 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.13883522 |
| 49 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.13220749 |
| 50 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.12865995 |
| 51 | ABC transporters_Homo sapiens_hsa02010 | 1.11601132 |
| 52 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.06110558 |
| 53 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.05958025 |
| 54 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.04580488 |
| 55 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.99277102 |
| 56 | Sulfur relay system_Homo sapiens_hsa04122 | 0.98211156 |
| 57 | Lysine degradation_Homo sapiens_hsa00310 | 0.87579701 |
| 58 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.84763955 |
| 59 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.81962599 |
| 60 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.80247759 |
| 61 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.77412715 |
| 62 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.77052596 |
| 63 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.74669893 |
| 64 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.71285516 |
| 65 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.60718483 |
| 66 | Metabolic pathways_Homo sapiens_hsa01100 | 0.49606455 |
| 67 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.41286322 |
| 68 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.31197853 |
| 69 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.28953360 |
| 70 | Pertussis_Homo sapiens_hsa05133 | 0.26744405 |
| 71 | Galactose metabolism_Homo sapiens_hsa00052 | 0.25546217 |
| 72 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.25497005 |
| 73 | Prion diseases_Homo sapiens_hsa05020 | 0.25398651 |
| 74 | Insulin resistance_Homo sapiens_hsa04931 | 0.21961574 |
| 75 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.20295953 |
| 76 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.18082436 |
| 77 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.17750463 |
| 78 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.15882351 |
| 79 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.11763981 |
| 80 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.07132073 |
| 81 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.06945070 |
| 82 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.01279824 |
| 83 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.00817237 |
| 84 | Bladder cancer_Homo sapiens_hsa05219 | -0.2044662 |
| 85 | Lysosome_Homo sapiens_hsa04142 | -0.2021645 |
| 86 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1977704 |
| 87 | Other glycan degradation_Homo sapiens_hsa00511 | -0.1935167 |
| 88 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1778838 |
| 89 | Mineral absorption_Homo sapiens_hsa04978 | -0.1744296 |
| 90 | Hepatitis C_Homo sapiens_hsa05160 | -0.1634707 |
| 91 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.1627088 |
| 92 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1603636 |
| 93 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.1445933 |
| 94 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1368588 |
| 95 | Serotonergic synapse_Homo sapiens_hsa04726 | -0.1292466 |
| 96 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1290458 |
| 97 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1269195 |
| 98 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.1248303 |
| 99 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.1238104 |
| 100 | Amoebiasis_Homo sapiens_hsa05146 | -0.1129181 |
| 101 | Circadian rhythm_Homo sapiens_hsa04710 | -0.1128227 |
| 102 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.0970793 |
| 103 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.0934174 |
| 104 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.0871467 |
| 105 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.0748628 |
| 106 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0721423 |
| 107 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | -0.0698421 |
| 108 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.0582354 |
| 109 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.0577936 |

